Published on Nov 28, 2024
Daily Editorials Analysis
Editorials/Opinions Analysis For UPSC 28 November 2024
Editorials/Opinions Analysis For UPSC 28 November 2024

Contents:

  1. Ban this carcinogenic ‘heart-burn’ drug
  2. Schooling in India in times of poor air quality

Ban this carcinogenic ‘heart-burn’ drug


Relevance : GS 2 (Health , Governance )

Practice Question: Discuss the regulatory challenges in India regarding drug safety, with reference to the Ranitidine carcinogenic drug.How to ensure better drug safety (250 Words )

GSK’s $2.2 Billion Settlement

  • GSK settled lawsuits worth $2.2 billion in the U.S. regarding Zantac (Ranitidine).
  • The drug was found to contain excessive levels of N-nitrosodimethylamine (NDMA), a potent carcinogen.

 Findings by Valisure

  • Tests revealed NDMA levels exceeding 3,000,000 nanograms in some Ranitidine samples.
  • U.S. permissible limit for NDMA is only 96 nanograms.
  • High NDMA levels are attributed to molecular stability issues, not specific to GSK.

 Global Regulatory Response

  • U.S. FDA and European Medical Agency (EMA) banned Ranitidine sales in 2020.
  • GSK voluntarily withdrew Ranitidine products from India in 2020.

India’s Inaction

  • India’s Ministry of Health has not banned Ranitidine despite global alerts.
  • Other companies continue to manufacture and sell Ranitidine in India.

Key Concerns

  • Why didn’t Indian regulators detect impurities in Ranitidine earlier?
  • Why hasn’t India banned Ranitidine despite substitutes like famotidine, cimetidine, and omeprazole?

Regulatory Framework in India

  • Indian Pharmacopeia Commission (IPC) under the Ministry of Health sets impurity limits and testing protocols.
  • IPC provides reference standards for drug quality assessments.

Quality Control:

  • State drug controllers issue manufacturing licenses.
  • State and Central drug inspectors conduct random sampling and testing.

IPC’s Role in the NDMA Issue

  • IPC failed to detect NDMA in Ranitidine or update permissible limits and testing protocols post-2020.
  • Access to the Indian Pharmacopeia is restricted due to its high cost (₹50,000).
  • Public health standards like the Pharmacopeia should ideally be accessible for free.

Enforcement Challenges

  • Drug manufacturers failing to meet impurity standards should be prosecuted.
  • Manufacturers must stop production of Ranitidine if standards cannot be met.

Ban on Drugs with Public Health Risks

  • Only the central government can ban drugs under Section 26A of the Drugs and Cosmetics Act, 1940.
  • The Drug Regulation Section in the Ministry of Health, often headed by non-specialists, lacks technical expertise.

Call for Action

  • After GSK’s settlement, the Ministry of Health must ban Ranitidine immediately under Section 26A.
  • Strengthening technical competence in regulatory bodies is necessary for public safety.

Schooling in India in Times of Poor Air Quality


Relevance : GS 2(Governance), GS 3(Environment)

Practice Question:Evaluate how school closures can help in combat against  air pollution. Suggest effective policies . (250 Words)

  • AQI Thresholds: Harm starts at AQI >50, but current focus on “severe” levels (>400) normalizes ongoing health risks.
  • Impact on Children: Air quality is similar at home and school; school closures cause learning and nutritional losses.

Problems with Online Classes

  • Not a substitute for physical learning; screen exposure harms young children.
  • Loss of holistic development and mid-day meals for underprivileged students.

Face Mask Concerns

  • Blanket mandates lack scientific basis, especially for children under 12.
  • Masks are redundant in air purifier setting.

Recommendations

  •  Keep schools open: Avoid closures; halt outdoor activities during poor AQI.
  • Personalized mask use: Follow medical advice, not uniform mandates.
  • Enhance air quality in schools: Use purifiers and ensure sealed classrooms.
  • Prioritize physical learning: Discourage hybrid/online models.
  •  Health support: Promote regular checkups and vaccinations for vulnerable groups.

Policy Perspective

  • GRAP measures disproportionately harm the poor.
  • Delink school closures from AQI-based triggers.
  • Focus on scientifically informed, pro-children policies.

Conclusion: School closures may not serve the purpose efficiently. A nuanced and child centric approach is need of the hour.